Coamorphous drug systems: Enhanced physical stability and dissolution rate of indomethacin and naproxen

Molecular Pharmaceutics

Volumn 8, Issue 5, 2011, Pages 1919-1928

  Löbmann, Korbinian ^a   Laitinen, Riikka ^a   Grohganz, Holger ^b   Gordon, Keith C ^a   Strachan, Clare ^a   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

coamorphous; Gordon Taylor equation; intrinsic dissolution; naproxen indomethacin; stability; synchronized release

Indexed keywords

INDOMETACIN; NAPROXEN;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; GLASS TRANSITION TEMPERATURE; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THERMOGRAPHY; X RAY POWDER DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG COMBINATIONS; DRUG STABILITY; INDOMETHACIN; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NAPROXEN; POWDER DIFFRACTION; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRANSITION TEMPERATURE;

EID: 80053505508     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp2002973     Document Type: Article

References (33)

1. Aaltonen, J.; Rades, T. Towards Physico-Relevant Dissolution Testing: The Importance of Solid-State Analysis in Dissolution Dissolution Technol. 2009, 16, 47-54
2. Hancock, B. C.; Zografi, G. Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 1997, 86 (1) 1-12
3. Hancock, B. C.; Parks, M. What is the True Solubility Advantage for Amorphous Pharmaceuticals? Pharm. Res. 2000, 17 (4) 397-404 (Pubitemid 30395293)
4. Kaushal, A. M.; Gupta, P.; Bansal, A. K. Amorphous drug delivery systems: Molecular aspects, design and performance Crit. Rev. Ther. Drug Carrier Syst. 2004, 21, 133-193 (Pubitemid 41647581)
5. Van den Mooter, G.; Wuyts, M.; Blaton, N.; Busson, R.; Grobet, P.; Augustijns, P.; Kinget, R. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25 Eur. J. Pharm. Sci. 2001, 12 (3) 261-269
6. Forster, A.; Hempenstall, J.; Rades, T. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers J. Pharm. Pharmacol. 2001, 53 (3) 303-315 (Pubitemid 32229189)
7. Vasconcelos, T.; Sarmento, B.; Costa, P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discovery Today 2007, 12 (23-24) 1068-1075 (Pubitemid 350186132)
8. Serajuddin, A. T. M. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs J. Pharm. Sci. 1999, 88 (10) 1058-1066
9. Shrivastava, A. R.; Ursekar, B.; Kapadia, C. J. Design, Optimization, Preparation and Evaluation of Dispersion Granules of Valsartan and Formulation into Tablets Curr. Drug Delivery 2009, 6, 28-37
10. Kaur, R.; Grant, D. J. W.; Eaves, T. Comparison of polyethylene glycol and polyoxyethylene stearate as excipients for solid dispersion systems of griseofulvin and tolbutamide II J. Pharm. Sci. 1980, 69 (11) 1321-1326 (Pubitemid 11162729)
11. Chieng, N.; Aaltonen, J.; Saville, D.; Rades, T. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation Eur. J. Pharm. Biopharm. 2009, 71 (1) 47-54
12. Allesa, M.; Chieng, N.; Rehder, S.; Rantanen, J.; Rades, T.; Aaltonen, J. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation J. Controlled Release 2009, 136 (1) 45-53
13. Yamamura, S.; Gotoh, H.; Sakamoto, Y.; Momose, Y. Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system Eur. J. Pharm. Biopharm. 2000, 49 (3) 259-265 (Pubitemid 30229875)
14. Yamamura, S.; Gotoh, H.; Sakamoto, Y.; Momose, Y. Physicochemical properties of amorphous salt of cimetidine and diflunisal system Int. J. Pharm. 2002, 241 (2) 213-221 (Pubitemid 34718023)
15. Carstensen, J. T. Advanced pharmaceutical solids; Marcel Dekker: New York, 2001; Vol. 110.
16. Chiou, W. L.; Riegelman, S. Pharmaceutical applications of solid dispersion systems J. Pharm. Sci. 1971, 60 (9) 1281-1302
17. van Drooge, D. J.; Hinrichs, W. L. J.; Visser, M. R.; Frijlink, H. W. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques Int. J. Pharm. 2006, 310 (1-2) 220-229 (Pubitemid 43287987)
18. del Arco, M.; Gutiérrez, S.; Martín, C.; Rives, V.; Rocha, J. Synthesis and characterization of layered double hydroxides (LDH) intercalated with non-steroidal anti-inflammatory drugs (NSAID) J. Solid State Chem. 2004, 177 (11) 3954-3962
19. 3 Acta Crystallogr. 1985, C41, 280-282
20. Aaltonen, J.; Gordon, K. C.; Strachan, C. J.; Rades, T. Perspectives in the use of spectroscopy to characterise pharmaceutical solids Int. J. Pharm. 2008, 364 (2) 159-169
21. Taylor, L. S.; Zografi, G. Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions Pharm. Res. 1997, 14 (12) 1691-1698 (Pubitemid 28062912)
22. Heinz, A.; Gordon, K. C.; McGoverin, C. M.; Rades, T.; Strachan, C. J. Understanding the solid-state forms of fenofibrate-A spectroscopic and computational study Eur. J. Pharm. Biopharm. 2009, 71 (1) 100-108
23. Strachan, C. J.; Rades, T.; Gordon, K. C. A theoretical and spectroscopic study of γ-crystalline and amorphous indometacin J. Pharm. Pharmacol. 2007, 59 (2) 261-269 (Pubitemid 46203064)
24. Gupta, M. K.; Bogner, R. H.; Goldman, D.; Tseng, Y.-C. Mechanism for Further Enhancement in Drug Dissolution from Solid-Dispersion Granules upon Storage Pharm. Dev. Technol. 2002, 7 (1) 103-112 (Pubitemid 35154420)
25. Kim, Y.; Song, H.; Park, I. Refinement of the structure of naproxen, (+)-6-methoxy-α-methyl-2-naphthaleneacetic acid Arch. Pharmacal Res. 1987, 10 (4) 232-238
26. Wu, T.; Sun, Y.; Li, N.; de Villiers, M. M.; Yu, L. Inhibiting Surface Crystallization of Amorphous Indomethacin by Nanocoating Langmuir 2007, 23 (9) 5148-5153 (Pubitemid 46732007)
27. Gupta, P. K. Non-crystalline solids: glasses and amorphous solids J. Non-Cryst. Solids 1996, 195 (1-2) 158-164 (Pubitemid 126347265)
28. Shamblin, S. L.; Huang, E. Y.; Zografi, G. The effects of co-lyophilized polymeric additives on the glass transition temperature and crystallization of amorphous sucrose J. Therm. Anal. Calorim. 1996, 47 (5) 1567-1579 (Pubitemid 126794510)
29. Taylor, L. S.; Zografi, G. Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures J. Pharm. Sci. 1998, 87 (12) 1615-1621 (Pubitemid 28559651)
30. Shamblin, S. L.; Taylor, L. S.; Zografi, G. Mixing behavior of colyophilized binary systems J. Pharm. Sci. 1998, 87 (6) 694-701 (Pubitemid 28268567)
31. Gupta, P.; Thilagavathi, R.; Chakraborti, A. K.; Bansal, A. K. Role of Molecular Interaction in Stability of Celecoxib-PVP Amorphous Systems Mol. Pharmaceutics 2005, 2 (5) 384-391 (Pubitemid 41503679)
32. Forster, A.; Hempenstall, J.; Tucker, I.; Rades, T. The Potential of Small-Scale Fusion Experiments and the Gordon-Taylor Equation to Predict the Suitability of Drug/Polymer Blends for Melt Extrusion Drug Dev. Ind. Pharm. 2001, 27 (6) 549-560 (Pubitemid 32803574)
33. Breitenbach, J. Melt extrusion: from process to drug delivery technology Eur. J. Pharm. Biopharm. 2002, 54 (2) 107-117 (Pubitemid 34919382)